secwatch.observer — SEC 8-K summary
======================================

Issuer:     OptimizeRx Corp (OPRX)
CIK:        0001448431
Form:       8-K/A
Filed at:   2024-01-05T23:59:59+00:00
Accession:  0001213900-24-001616
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OptimizeRx completes acquisition of Medicx Health; FY2022 revenue $28.1M
------------------------------------------------------------------------

- Medicx FY2022: revenue $28.1M, net income $4.5M; FY2021: revenue $18.5M, net income $0.8M.
- Deal closed Oct 24, 2023; this amendment provides audited and pro forma financials.
- Medicx balance sheet Dec 2022: total assets $18.6M, stockholders' equity $12.4M.
- Pro forma combined balance sheet at June 30, 2023 and statements of ops included.
- Medicx revenue grew 51% YoY from 2021 to 2022; net income increased 5.8x.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1448431/000121390024001616/0001213900-24-001616-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1448431/000121390024001616/ea191205-8ka1_optimizerx.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-001616

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer